Showing results (71-80 of 518) with videos related to
Sort By:
Pageof 52
Frontiers in Immunology|August 23, 2013
Peripherally induced tregs - role in immune homeostasis and autoimmunityMahesh Yadav, Stephen Stephan, Jeffrey A BluestoneArthritis and Rheumatism|September 1, 1975
Wegener's granulomatosis. Long-term followup of patients treated with cyclophosphamideM J Reza, L Dornfeld, L S Goldberg, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 20, 1998
Partial TCR signals delivered by FcR-nonbinding anti-CD3 monoclonal antibodies differentially regulate individual Th subsetsJ A Smith, Q Tang, J A BluestonePrincess Takamatsu Symposia|January 1, 1988
In vivo administration of anti-CD3 monoclonal antibody can activate immune responses thus preventing malignant tumor growthR Hirsch, J D Ellenhorn, J A BluestoneTransplantation|March 15, 1996
In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cellsE S Woodle, S Hussein, J A BluestoneNature|November 19, 1987
Major histocompatibility complex-linked specificity of gamma delta receptor-bearing T lymphocytesL A Matis, R Cron, J A BluestoneJournal of Visualized Experiments : Jove|November 8, 2008
Transplantation of pancreatic islets into the kidney capsule of diabetic miceGregory L Szot, Pavel Koudria, Jeffrey A BluestoneCurrent Opinion in Organ Transplantation|July 16, 2010
Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortiaLaurence A Turka, Kathryn Wood, Jeffrey A BluestoneNature Reviews. Rheumatology|October 3, 2009
Regulatory T cells as therapeutic targets in rheumatoid arthritisJonathan H Esensten, David Wofsy, Jeffrey A BluestoneJournal of Immunology (Baltimore, Md. : 1950)|April 1, 1990
Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated miceJ D Ellenhorn, H Schreiber, J A BluestonePageof 52